Show simple item record

dc.contributor.authorMatías-Guiu, JA
dc.contributor.authorGómez-Pinedo, U
dc.contributor.authorForero, Lucía
dc.contributor.authorPytel, V
dc.contributor.authorCano, F
dc.contributor.authorMoreno-Ramos, T
dc.contributor.authorCabrera-Martín, MN
dc.contributor.authorMatías-Guiu, J
dc.contributor.authorGonzález Rosa, Javier Jesús 
dc.contributor.otherPsicologíaes_ES
dc.date.accessioned2024-02-06T17:55:22Z
dc.date.available2024-02-06T17:55:22Z
dc.date.issued2019-11-26
dc.identifier.issn1387-2877
dc.identifier.urihttp://hdl.handle.net/10498/30690
dc.description.abstractBackground: Primary progressive aphasia (PPA) is a heterogeneous syndrome that is difficult to diagnose at early stages. Plasma neurofilament light chain (NFL) has been proposed as a potential biomarker for PPA. Objective: To examine the diagnostic properties of plasma NFL in PPA and to evaluate its association with clinical stages of the disease and brain metabolism. Methods: Our study included 80 participants (13 with non-fluent, 12 with semantic, and 16 with logopenic variant PPA; 13 with amnestic Alzheimer's disease [AD]; 13 with behavioral variant frontotemporal dementia; and 13 healthy controls). Plasma NFL concentration was measured using a high-sensitivity enzyme-linked immunosorbent assay (ELISA) kit. PET imaging was performed in a subgroup of patients. Results: NFL discriminated patients from controls with an area under the curve of 0.914 (95% CI, 0.843-0.984; p < 0.001) (cut-off: 76.46 pg/mL; 94% sensitivity, 76.9% specificity). There were no significant differences between clinical syndromes (PPA subtypes), the main clinical forms of dementia (frontotemporal dementia and AD), or the expected pathological groups (frontotemporal lobar degeneration-tau [FTLD-tau], FTLD-TDP43, and AD). NFL levels showed weak to moderate correlations with age and functional scale score. We found no significant correlation with the extent of hypometabolism observed on FDG-PET images. Conclusion: Plasma NFL is a non-specific marker of neurodegeneration, and may be helpful in the diagnosis of PPA. However, NFL does not permit differential diagnosis between PPA subtypes and is not correlated with the extent of neurodegeneration.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherIOS PRESSes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAlzheimer’s diseasees_ES
dc.subjectbiomarkerses_ES
dc.subjectfrontotemporal dementiaes_ES
dc.subjectneurofilamentes_ES
dc.subjectpositron emission tomographyes_ES
dc.subjectprimary progressive aphasiaes_ES
dc.titlePlasma Neurofilament Light Chain in Primary Progressive Aphasia and Related Disorders: Clinical Significance and Metabolic Correlateses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.description.physDesc72(3):773-782. doi: 10.3233/JAD-190838es_ES
dc.identifier.doi10.3233/JAD-190838
dc.type.hasVersionSMURes_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
This work is under a Creative Commons License Attribution-NonCommercial-NoDerivatives 4.0 Internacional